Jeanette Acosta Invest in Women’s Health Act of 2024

[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 10287 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 10287 To provide women with increased access to preventive and life-saving cancer screening. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES December 4, 2024 Mr. Gomez (for himself, Ms. Barragan, Ms. Brownley, Mr. Carter of Louisiana, Mrs. Cherfilus-McCormick, Ms. Chu, Ms. Clarke of New York, Mr. Cohen, Ms. DeGette, Mrs. Ramirez, Mr. Deluzio, Mrs. Dingell, Mr. Evans, Mr. Goldman of New York, Mr. Grijalva, Mr. Johnson of Georgia, Ms. Kamlager-Dove, Mr. Krishnamoorthi, Ms. Lee of California, Ms. McClellan, Ms. McCollum, Mr. Moulton, Mrs. Torres of California, Ms. Norton, Mr. Peters, Mr. Khanna, Mr. Robert Garcia of California, Mr. Ruppersberger, Ms. Scanlon, Ms. Sewell, Mr. Soto, Ms. Strickland, Ms. Tlaib, Mr. Tonko, Mr. Vargas, Ms. Velazquez, Ms. Wasserman Schultz, and Mrs. Watson Coleman) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To provide women with increased access to preventive and life-saving cancer screening. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Jeanette Acosta Invest in Women's Health Act of 2024''. SEC. 2. PURPOSE. It is the purpose of this Act to provide women with increased access to preventive and life-saving cancer screening (including clinical breast exams and breast, cervical, ovarian, uterine, vaginal, and vulvar cancer screening), as well as access to appropriate care and early detection (including via diagnostic testing and treatment and provider education and awareness of best clinical practices), provided by leading women's health care providers who-- (1) serve populations most at risk